Opaleye Management Inc.

10% Owner
Opaleye Management Inc.
$214,031,000.00
%
COMPANY
SHARES
NET TOTAL
11.34%
HARROW HEALTH INC
3,332,732
$24,262,000.00
11.22%
OCULAR THERAPEUTIX INC
5,974,800
$24,019,000.00
6.30%
CODEXIS INC
1,288,450
$13,477,000.00
5.85%
CRINETICS PHARMACEUTICALS INC
671,300
$12,520,000.00
5.55%
CYTOKINETICS INC
302,500
$11,885,000.00
5.38%
TELA BIO INC
1,643,367
$11,520,000.00
4.15%
PROTARA THERAPEUTICS INC
2,684,167
$8,885,000.00
3.86%
TRACON PHARMACEUTICALS INC
4,125,322
$8,251,000.00
3.69%
KINIKSA PHARMACEUTICALS LTD
814,250
$7,890,000.00
3.58%
MERUS N.V.
338,000
$7,652,000.00
3.56%
KEROS THERAPEUTICS INC
276,000
$7,626,000.00
3.13%
INHIBRX INC
590,000
$6,697,000.00
3.01%
ETON PHARMACEUTICALS INC
2,462,500
$6,452,000.00
2.74%
XOMA CORP DEL
263,050
$5,861,000.00
2.61%
REATA PHARMACEUTICALS INC
183,750
$5,584,000.00
2.59%
CUTERA
147,700
$5,539,000.00
2.26%
MERSANA THERAPEUTICS INC
1,047,000
$4,837,000.00
1.93%
VAXCYTE INC
190,000
$4,134,000.00
1.81%
STEREOTAXIS INC
2,099,971
$3,864,000.00
1.68%
EDGEWISE THERAPEUTICS INC
451,400
$3,593,000.00
1.60%
908 DEVICES INC
166,406
$3,426,000.00
1.39%
CHIMERIX INC
1,430,000
$2,974,000.00
1.27%
FORTRESS BIOTECH INC
3,247,180
$2,727,000.00
1.13%
CELLDEX THERAPEUTICS INC NEW
90,000
$2,426,000.00
1.06%
LIQUIDIA CORPORATION
521,500
$2,274,000.00
1.06%
4D MOLECULAR THERAPEUTICS INC
325,000
$2,269,000.00
1.00%
PROQR THERAPEUTICS NV
2,740,000
$2,131,000.00
0.91%
UROGEN PHARMA LTD
238,670
$1,955,000.00
0.86%
VERASTEM INC
1,590,000
$1,844,000.00
0.85%
LARIMAR THERAPEUTICS INC
932,814
$1,828,000.00
0.70%
RHYTHM PHARMACEUTICALS INC
362,000
$1,502,000.00
0.63%
IMPEL PHARMACEUTICALS INC
144,642
$1,348,000.00
0.29%
NEOLEUKIN THERAPEUTICS INC
610,000
$628,000.00
0.29%
MACROGENICS INC
208,300
$614,000.00
0.21%
NEUROPACE INC
90,100
$446,000.00
0.19%
FORMA THERAPEUTICS HLDGS INC
58,700
$404,000.00
0.16%
MARINUS PHARMACEUTICALS INC
68,900
$333,000.00
0.16%
OPTINOSE INC
90,970
$333,000.00
0.01%
BIOLINERX LTD
16,667
$21,000.00